Skip to main content

Animations

MJFF Publications

5271 - 5280 of 6255 Results
Title
Year
  • Year
  • 2017
  • 2014
  • 2011
  • 2024
  • 2023
  • 2022
  • 2024
  • 2021
  • 2021
  • 2016
  • Summary Details
    OPEN
    Title: Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.aam9080
    Citation Count: 736
  • Summary Details
    OPEN
    Title: Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2014/606427
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets
    Journal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbadis.2011.07.004
    Citation Count: 61
  • Summary Details
    OPEN
    Title: A highly efficient, scalable pipeline for fixed feature extraction from large-scale high-content imaging screens
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.isci.2024.111434
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteins
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00564-3
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemic
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049755
    Citation Count: 0
  • Summary Details
    OPEN
    Title: CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated Protein
    Journal Name: Journal of Chemical Information and Modeling
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jcim.4c01267
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial
    Journal Name: Genomics, Proteomics & Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.gpb.2021.08.009
    Citation Count: 69
  • Summary Details
    OPEN
    Title: miRMaster 2.0: multi-species non-coding RNA sequencing analyses at scale
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkab268
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20160557
    Citation Count: 156
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.